Etanercept and efalizumab for the treatment of adults with psoriasis

  • Technology appraisal guidance
  • TA103
  • Published: 

Appeal details: Efalizumab and etanercept for psoriasis

NICE Guidance has moved

Please use Find Guidance above to find NICE guidance topics

No last updated information available